Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).
Saeki H, Mabuchi T, Asahina A, Abe M, Igarashi A, Imafuku S, Okubo Y, Komine M, Sano S, Torii H, Morita A, Yotsuyanagi H, Watanabe A, Ohtsuki M; Committee for reviewing the safety of molecularly targeted drugs for psoriasis, Japanese Dermatological Association. Saeki H, et al. Among authors: sano s. J Dermatol. 2023 Feb;50(2):e41-e68. doi: 10.1111/1346-8138.16691. Epub 2022 Dec 29. J Dermatol. 2023. PMID: 36582113
Guidelines for the diagnosis and treatment of vitiligo in Japan.
Oiso N, Suzuki T, Wataya-Kaneda M, Tanemura A, Tanioka M, Fujimoto T, Fukai K, Kawakami T, Tsukamoto K, Yamaguchi Y, Sano S, Mitsuhashi Y, Nishigori C, Morita A, Nakagawa H, Mizoguchi M, Katayama I. Oiso N, et al. Among authors: sano s. J Dermatol. 2013 May;40(5):344-54. doi: 10.1111/1346-8138.12099. Epub 2013 Feb 27. J Dermatol. 2013. PMID: 23441960
The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist.
Sugiura K, Takemoto A, Yamaguchi M, Takahashi H, Shoda Y, Mitsuma T, Tsuda K, Nishida E, Togawa Y, Nakajima K, Sakakibara A, Kawachi S, Shimizu M, Ito Y, Takeichi T, Kono M, Ogawa Y, Muro Y, Ishida-Yamamoto A, Sano S, Matsue H, Morita A, Mizutani H, Iizuka H, Muto M, Akiyama M. Sugiura K, et al. Among authors: sano s. J Invest Dermatol. 2013 Nov;133(11):2514-2521. doi: 10.1038/jid.2013.230. Epub 2013 May 22. J Invest Dermatol. 2013. PMID: 23698098 Free article.
Japanese guidance for use of biologics for psoriasis (the 2013 version).
Ohtsuki M, Terui T, Ozawa A, Morita A, Sano S, Takahashi H, Komine M, Etoh T, Igarashi A, Torii H, Asahina A, Nemoto O, Nakagawa H; Biologics Review Committee of the Japanese Dermatological Association. Ohtsuki M, et al. Among authors: sano s. J Dermatol. 2013 Sep;40(9):683-95. doi: 10.1111/1346-8138.12239. J Dermatol. 2013. PMID: 24033880
Epidemiological analysis of psoriatic arthritis patients in Japan.
Yamamoto T, Ohtsuki M, Sano S, Igarashi A, Morita A, Okuyama R, Kawada A; Working Group of the Epidemiological Survey in the Japanese Society for Psoriasis Research. Yamamoto T, et al. Among authors: sano s. J Dermatol. 2016 Oct;43(10):1193-1196. doi: 10.1111/1346-8138.13342. J Dermatol. 2016. PMID: 26992450
Prevalence and current therapies of psoriatic arthritis in Japan: A survey by the Japanese Society of Psoriasis Research in 2016.
Yamamoto T, Ohtsuki M, Sano S, Igarashi A, Morita A, Okuyama R, Kawada A; Working Group of the Epidemiological Survey in the Japanese Society for Psoriasis Research. Yamamoto T, et al. Among authors: sano s. J Dermatol. 2017 Jun;44(6):e121. doi: 10.1111/1346-8138.13800. Epub 2017 Mar 3. J Dermatol. 2017. PMID: 28256750 No abstract available.
Neutrophils are not the dominant interleukin-17 producer in psoriasis.
Yamanaka K, Yamagiwa A, Akeda T, Kondo M, Kakeda M, Habe K, Imafuku S, Sano S, Mizutani H. Yamanaka K, et al. Among authors: sano s. J Dermatol. 2017 Jul;44(7):e170-e171. doi: 10.1111/1346-8138.13807. Epub 2017 Mar 11. J Dermatol. 2017. PMID: 28295564 No abstract available.
1,104 results